check_circleStudy Completed

Diagnostic imaging, Central Nervous System

Bayer Identifier:

Trial_A23BSA

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Open clinical study with Gd-DTPA (gadopentetate dimeglumine) in cerebral and spinal diseases

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

5 - N/A
  • -

  • -

Trial summary

Enrollment Goal
443
Trial Dates
March 1986 - April 1987
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

Open clinical studies with Gd-DTPA (gadopentetate dimeglumine) in cerebral and spinal diseases - Summary of studies at 22 hospitals
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.